Article
Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
Infection and immunity - 1 Apr 2000
Dreisbach V C, Cowley S, Elkins K L
Abstract excerpt
Previous results have demonstrated that nonspecific protective immunity against lethal Francisella tularensis live vaccine strain (LVS) or Listeria monocytogenes infection can be stimulated either by sublethal infection with bacteria or by treatment with bacterial DNA given 3 days before lethal challenge. Here we characterize the ability of purified lipopolysaccharide (LPS) from F. tularensis LVS to stimulate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
